Eli Lilly (LLY) CEO says that the Co. will invest heavily in R&D with focus extending beyond obesity
Importance
Level 1
#ELI LILLY & CO#LLY.US#EQUITIES#EU SESSION#US SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#ELI LILLY AND CO#LLY#US EQUITIES